Myriant pulls plug on $125 mln IPO – Fortune


Fortune reported that Myriant has withdrawn its planned $125 million IPO. The publication said that no reasons were given. Based in Quincy, Mass., Myriant is a biochemical company. Its backers include Plainfield Asset Management and PTT Chemical International.

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.